429 related articles for article (PubMed ID: 30043491)
1. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell lung cancer cells by activating the NF-κB pathway.
Li Y; Deng L; Zhao X; Li B; Ren D; Yu L; Pan H; Gong Q; Song L; Zhou X; Dai T
J Pathol; 2018 Nov; 246(3):366-378. PubMed ID: 30043491
[TBL] [Abstract][Full Text] [Related]
2. An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-κB Signaling.
Wu G; Song L; Zhu J; Hu Y; Cao L; Tan Z; Zhang S; Li Z; Li J
Cancer Res; 2018 Nov; 78(22):6399-6412. PubMed ID: 30254148
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits the proliferation and invasion of ovarian cancer cells by suppressing tripartite motif-containing 37-induced tumor necrosis factor receptor-associated factor 2 ubiquitination.
Zheng Y; Zhang H; Sun H
Cancer Sci; 2022 Nov; 113(11):3776-3786. PubMed ID: 35950370
[TBL] [Abstract][Full Text] [Related]
4. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
5. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
Huang RS; Zheng YL; Zhao J; Chun X
Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
[TBL] [Abstract][Full Text] [Related]
6. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway.
Dai T; Zhang D; Cai M; Wang C; Wu Z; Ying Z; Wu J; Li M; Xie D; Li J; Song L
J Pathol; 2015 Feb; 235(3):490-501. PubMed ID: 25385148
[TBL] [Abstract][Full Text] [Related]
7. TRIM13 inhibited cell proliferation and induced cell apoptosis by regulating NF-κB pathway in non-small-cell lung carcinoma cells.
Xu L; Wu Q; Zhou X; Wu Q; Fang M
Gene; 2019 Oct; 715():144015. PubMed ID: 31357025
[TBL] [Abstract][Full Text] [Related]
8. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
9. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
[TBL] [Abstract][Full Text] [Related]
10. TRIM25 Promotes TNF-α-Induced NF-κB Activation through Potentiating the K63-Linked Ubiquitination of TRAF2.
Liu Y; Liu K; Huang Y; Sun M; Tian Q; Zhang S; Qin Y
J Immunol; 2020 Mar; 204(6):1499-1507. PubMed ID: 32024699
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
[TBL] [Abstract][Full Text] [Related]
12. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.
Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z
Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337
[TBL] [Abstract][Full Text] [Related]
13. TRAF2 is an NF-κB-activating oncogene in epithelial cancers.
Shen RR; Zhou AY; Kim E; O'Connell JT; Hagerstrand D; Beroukhim R; Hahn WC
Oncogene; 2015 Jan; 34(2):209-16. PubMed ID: 24362534
[TBL] [Abstract][Full Text] [Related]
14. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
Cortes-Sempere M; Chattopadhyay S; Rovira A; Rodriguez-Fanjul V; Belda-Iniesta C; Tapia M; Cejas P; Machado-Pinilla R; Manguan-García C; Sánchez-Pérez I; Nistal M; Moratilla C; de Castro-Carpeño J; Gonzalez-Barón M; Albanell J; Perona R
Cancer Lett; 2009 Dec; 286(2):206-16. PubMed ID: 19553005
[TBL] [Abstract][Full Text] [Related]
15. RNF8-mediated regulation of Akt promotes lung cancer cell survival and resistance to DNA damage.
Xu Y; Hu Y; Xu T; Yan K; Zhang T; Li Q; Chang F; Guo X; Peng J; Li M; Zhao M; Zhen H; Xu L; Zheng D; Li L; Shao G
Cell Rep; 2021 Oct; 37(3):109854. PubMed ID: 34686341
[TBL] [Abstract][Full Text] [Related]
16. The PP4R1 subunit of protein phosphatase PP4 targets TRAF2 and TRAF6 to mediate inhibition of NF-κB activation.
Hadweh P; Habelhah H; Kieff E; Mosialos G; Hatzivassiliou E
Cell Signal; 2014 Dec; 26(12):2730-7. PubMed ID: 25134449
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.
Varfolomeev E; Izrael-Tomasevic A; Yu K; Bustos D; Goncharov T; Belmont LD; Masselot A; Bakalarski CE; Kirkpatrick DS; Vucic D
Biochem J; 2015 Feb; 466(1):45-54. PubMed ID: 25423073
[TBL] [Abstract][Full Text] [Related]
18. CNPY2 enhances resistance to apoptosis induced by cisplatin via activation of NF-κB pathway in human non-small cell lung cancer.
Yu D; Qin Y; Jun-Qiang L; Shun-Lin G
Biomed Pharmacother; 2018 Jul; 103():1658-1663. PubMed ID: 29864955
[TBL] [Abstract][Full Text] [Related]
19. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo.
Zhou B; Wang D; Sun G; Mei F; Cui Y; Xu H
Cell Physiol Biochem; 2018; 46(3):999-1008. PubMed ID: 29669316
[TBL] [Abstract][Full Text] [Related]
20. Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins.
Chen X; Sun X; Guan J; Gai J; Xing J; Fu L; Liu S; Shen F; Chen K; Li W; Han L; Li Q
Cell Physiol Biochem; 2017; 44(6):2322-2336. PubMed ID: 29258089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
